Search

Search Constraints

You searched for: Author/Creator Pochesci, Alessia

Search Results

2. Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trials. (November 2021)

3. EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease. (November 2019)